Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$122.0 - $145.31 $3.05 Million - $3.63 Million
-24,980 Reduced 88.83%
3,140 $406,000
Q2 2023

Aug 14, 2023

SELL
$122.5 - $147.16 $4.45 Million - $5.34 Million
-36,290 Reduced 56.34%
28,120 $3.49 Million
Q1 2023

May 15, 2023

SELL
$133.98 - $160.47 $2.74 Million - $3.28 Million
-20,420 Reduced 24.07%
64,410 $9.43 Million
Q4 2022

Feb 14, 2023

BUY
$129.72 - $159.85 $1.66 Million - $2.04 Million
12,770 Added 17.72%
84,830 $13.5 Million
Q3 2022

Nov 14, 2022

SELL
$126.59 - $161.18 $1.35 Million - $1.72 Million
-10,690 Reduced 12.92%
72,060 $9.61 Million
Q2 2022

Aug 16, 2022

BUY
$141.59 - $168.66 $2.31 Million - $2.76 Million
16,340 Added 24.6%
82,750 $12.9 Million
Q1 2022

May 16, 2022

SELL
$129.64 - $160.7 $11.2 Million - $13.9 Million
-86,280 Reduced 56.51%
66,410 $10.3 Million
Q4 2021

Feb 14, 2022

BUY
$119.87 - $145.67 $4.16 Million - $5.05 Million
34,670 Added 29.38%
152,690 $19.5 Million
Q3 2021

Nov 15, 2021

SELL
$128.64 - $184.79 $2.66 Million - $3.83 Million
-20,710 Reduced 14.93%
118,020 $15.4 Million
Q2 2021

Aug 16, 2021

BUY
$160.2 - $186.42 $2.23 Million - $2.6 Million
13,950 Added 11.18%
138,730 $24.6 Million
Q1 2021

May 17, 2021

BUY
$150.19 - $173.5 $18.7 Million - $21.6 Million
124,780 New
124,780 $20.5 Million
Q4 2018

Feb 14, 2019

SELL
$115.94 - $166.74 $591,294 - $850,374
-5,100 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$146.33 - $183.18 $307,293 - $384,678
2,100 Added 70.0%
5,100 $879,000
Q1 2018

May 15, 2018

SELL
$135.59 - $157.16 $27,118 - $31,432
-200 Reduced 6.25%
3,000 $453,000
Q4 2017

Feb 14, 2018

SELL
$131.06 - $150.39 $288,332 - $330,857
-2,200 Reduced 40.74%
3,200 $431,000
Q3 2017

Nov 14, 2017

BUY
$142.62 - $155.6 $770,148 - $840,240
5,400
5,400 $790,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Clough Capital Partners L P Portfolio

Follow Clough Capital Partners L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clough Capital Partners L P, based on Form 13F filings with the SEC.

News

Stay updated on Clough Capital Partners L P with notifications on news.